216 related articles for article (PubMed ID: 27636902)
1. The prevalence of HPV types in women with CIN 2-3 or cervical cancer in Haifa district, Israel.
Siegler E; Sharir K; Lavie O; Saked-Misan P; Machulki L; Auslender R; Segev Y
Minerva Ginecol; 2017 Jun; 69(3):211-217. PubMed ID: 27636902
[TBL] [Abstract][Full Text] [Related]
2. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
Wong AK; Chan RC; Nichols WS; Bose S
Cancer; 2009 Feb; 115(4):823-32. PubMed ID: 19127558
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Genotype Distribution of HPV Types in Women at Risk for Cervical Neoplasia in Israel.
Siegler E; Shiner M; Segev Y; Mackuli L; Lahat N; Lavie O
Isr Med Assoc J; 2017 Oct; 19(10):635-639. PubMed ID: 29103242
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
[TBL] [Abstract][Full Text] [Related]
5. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
[TBL] [Abstract][Full Text] [Related]
6. Low-Risk Human Papillomavirus Types in Cervical Intraepithelial Neoplasia 2-3 and in Invasive Cervical Cancer Patients.
Siegler E; Reichman Y; Kugelman N; Mackuli L; Lavie O; Ostrovsky L; Shaked-Mishan P; Segev Y
J Low Genit Tract Dis; 2019 Oct; 23(4):248-252. PubMed ID: 31592971
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
8. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
[TBL] [Abstract][Full Text] [Related]
9. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
[TBL] [Abstract][Full Text] [Related]
10. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
[TBL] [Abstract][Full Text] [Related]
11. Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women.
Eltoum IA; Chhieng DC; Roberson J; McMillon D; Partridge EE
Cancer; 2005 Aug; 105(4):194-8. PubMed ID: 15900575
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of human papillomavirus types 16, 18, and 45 in women with cervical intraepithelial changes: associations with colposcopic and histological findings.
Jarienė K; Vaitkienė D; Bartusevičius A; Tvarijonavičienė E; Minkauskienė M; Nadišauskienė R; Kruminis V; Kliučinskas M
Medicina (Kaunas); 2012; 48(1):22-30. PubMed ID: 22481371
[TBL] [Abstract][Full Text] [Related]
13. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of visual inspection with acetic acid in detecting high-grade cervical intraepithelial neoplasia in pre- and post-menopausal Thai women with minor cervical cytological abnormalities.
Poomtavorn Y; Suwannarurk K
Asian Pac J Cancer Prev; 2015; 16(6):2327-31. PubMed ID: 25824759
[TBL] [Abstract][Full Text] [Related]
15. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
Zhao C; Amin M; Weng B; Chen X; Kanbour-Shakir A; Austin RM
Arch Pathol Lab Med; 2013 Jul; 137(7):942-7. PubMed ID: 23050808
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
17. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
19. Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.
Kim CJ; Lee YS; Kwack HS; Yoon WS; Park TC; Park JS
Int J Gynecol Cancer; 2010 Aug; 20(6):1067-73. PubMed ID: 20683419
[TBL] [Abstract][Full Text] [Related]
20. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears.
Rozendaal L; Walboomers JM; van der Linden JC; Voorhorst FJ; Kenemans P; Helmerhorst TJ; van Ballegooijen M; Meijer CJ
Int J Cancer; 1996 Dec; 68(6):766-9. PubMed ID: 8980181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
